EUVIMEDEUVIMED entdecken
Open Access

Galectin-3 exacerbates autoimmune diabetes by limiting regulatory T cell differentiation and function

Lingxiang Xie iD, Rong Zhang iD, Hailan Zou iD, Jingyi Hu, Jiangming Deng iD, Jin Ding iD, Long Liu iD, Qiuqiu Lin, Bin Zhao iD, Aimin Xu iD, Zhiguang Zhou, Yang Xiao iD

Science Advances · 02.01.2026 · 12 (1)

DOI: 10.1126/sciadv.adz7916 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 02.01.2026. Verfasst von Lingxiang Xie und 11 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, and Department of Metabolism …. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, T-Lymphocytes, Regulatory, Galectin 3, Cell Differentiation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, the Scientific Research Program of FuRong Laboratory, the Natural Science Foundation of Hunan Province for Youths.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Galectin-3, a β-galactoside–binding lectin, has been implicated in several inflammatory and autoimmune diseases. However, the significance of circulating Galectin-3 in type 1 diabetes (T1D) remains unclear. Here, we report that compared to healthy controls, patients with T1D and their first-degree relatives (FDRs) exhibited significantly increased serum Galectin-3 levels primarily produced and secreted by monocytes/macrophages. Pharmacological inhibition (TD139) as well as knockout of Galectin-3 gene both attenuated Galectin-3–mediated suppression of regulatory T cells (T reg cells) and protected from insulitis and diabetes onset in NOD mice. Mechanistically, Galectin-3 bound to and activated lymphocyte activation gene 3 (LAG3), a receptor expressed on activated T cells, subsequently suppressing the MEK/ERK signaling pathway and thereby hindering T reg cell differentiation and function. In summary, our study identifies Galectin-3 as a potential biomarker for T1D and suggests that TD139 holds promise as a therapeutic candidate for patients with T1D and high serum Galectin-3 levels.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1T-Lymphocytes, RegulatoryGalectin 3Cell DifferentiationAnimalsHumansMiceMice, Inbred NODFemaleMaleLymphocyte ActivationLymphocyte Activation Gene 3 ProteinAntigens, CDBiomarkersAdultMice, KnockoutBlood ProteinsGalectins

Substanzen

Galectin 3Lymphocyte Activation Gene 3 ProteinAntigens, CDBiomarkersLGALS3 protein, humanBlood ProteinsGalectins

Autor:innen und Institutionen

  • National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South Univer…
  • Department of Metabolism and Endocrinology, The Fourth of Hospital of Changsha, Changsha, Hunan, China.
  • State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong, Hong Kong, China.
  • Department of Medicine, The University of Hong Kong, Hong Kong, China.
  • Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong, China.

ORCID-Profile: Lingxiang Xie, Rong Zhang, Hailan Zou, Jiangming Deng, Jin Ding, Long Liu, Bin Zhao, Aimin Xu, Yang Xiao

Förderung

  • National Natural Science Foundation of China
  • the Scientific Research Program of FuRong Laboratory
  • the Natural Science Foundation of Hunan Province for Youths
  • the key program of Natural Science Foundation of Hunan Province
  • Noncommunicable Chronic Diseases-National Science and Technology Major Project
  • the Science and Technology Innovation Program of Hunan Province

Zitieren

APA

Xie, L., Zhang, R., Zou, H., Hu, J., Deng, J., Ding, J., Liu, L., Lin, Q., Zhao, B., Xu, A., Zhou, Z., & Xiao, Y. (2026). Galectin-3 exacerbates autoimmune diabetes by limiting regulatory T cell differentiation and function. Science Advances, 12(1). https://doi.org/10.1126/sciadv.adz7916

Vancouver

Xie L, Zhang R, Zou H, Hu J, Deng J, Ding J, et al. Galectin-3 exacerbates autoimmune diabetes by limiting regulatory T cell differentiation and function. Science Advances. 2026;12(1). doi:10.1126/sciadv.adz7916

BibTeX
@article{Xie2026,
  author = {Xie, Lingxiang and Zhang, Rong and Zou, Hailan and Hu, Jingyi and Deng, Jiangming and Ding, Jin and Liu, Long and Lin, Qiuqiu and Zhao, Bin and Xu, Aimin and Zhou, Zhiguang and Xiao, Yang},
  title = {Galectin-3 exacerbates autoimmune diabetes by limiting regulatory T cell differentiation and function},
  journal = {Science Advances},
  year = {2026},
  volume = {12},
  number = {1},
  doi = {10.1126/sciadv.adz7916}
}
Kostenlos starten →